Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 25, 1998, Pages 14915-14919

  Elmets, Craig A ^a,b   Athar, Mohammad ^a,c   Tubesing, Karen A ^a   Rothaupt, Dinah ^a   Xu, Hui ^b   Mukhtar, Hasan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CELLULAR IMMUNITY; CHEMICAL CARCINOGENESIS; CONTACT ALLERGY; CONTROLLED STUDY; DNA ADDUCT; ENZYME ACTIVITY; GENE SEGREGATION; GENETIC SUSCEPTIBILITY; GENOTOXICITY; HISTOCOMPATIBILITY GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; GENES, MHC CLASS I; GENES, MHC CLASS II; IMMUNITY, CELLULAR; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; POLYCYCLIC COMPOUNDS;

ANIMALIA;

EID: 0032444353     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.25.14915     Document Type: Article

References (30)

1. DiGiovanni, J. (1992) Pharmacol. Ther. 54, 63-128.
2. Gonzalez, F. (1995) in Skin Cancer: Mechanisms and Human Relevance, ed. Mukhtar, H. (CRC, Boca Raton, FL), pp. 89-97.
3. Pelkonen, O. & Nebert, D. (1982) Pharmacol. Rev. 34, 189-222.
4. Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. (1986) Nature (London) 322, 78-80.
5. Conney, A. H. (1982) Cancer Res. 42, 4875-4917.
6. DiGiovanni, J. (1995) Prog. Clin. Biol. Res. 391, 195-212.
7. Klemme, J., Mukhtar, H. & Elmets, C. (1987) Cancer Res. 47, 6074-6078.
8. Anderson, C., Hehr, A., Robbins, R., Hasan, R., Athar, M., Mukhtar, H. & Elmets, C. A. (1995) J. Immunol. 155, 3530-3537.
9. Luster, M. & Rosenthal, G. (1993) Environ. Health Perspect. 100, 219-226.
10. Ruby, J., Halliday, G. & Muller, H. (1989) J. Invest. Dermatol. 92, 150-155.
11. Old, L., Benacerraf, B. & Carswell, E. (1963) Nature (London) 198, 1215-1216.
12. Pomeranz, J. (1972) J. Natl. Cancer Inst. 48, 1513-1517.
13. Pomeranz, J., Carney, J. & Alarif, A. (1980) J. Invest. Dermatol. 75, 488-490.
14. Mukhtar, H., Das, M. & Bickers, D. (1986) Cancer Lett. 31, 147-151.
15. Xu, H., DiIulio, N. & Fairchild, R. (1996) J. Exp. Med. 183, 1001-1012.
16. Streilein, J. & Bergstresser, P. R. (1988) Immunogenetics 27, 252-258.
17. Agarwal, R., Katiyar, S., Zaidi, S. & Mukhtar, H. (1992) Cancer Res. 52, 3582-3588.
18. Mukhtar, H., Mercurio, M. & Agarwal, R. (1995) in Skin Cancer: Mechanisms and Human Relevance, ed. Mukhtar, H. (CRC, Boca Raton, FL), pp. 3-8.
19. Pellis, N. & Kahan, B. (1975) J. Immunol. 115, 1717-1722.
20. Leffell, M. & Coggin, J. J. (1977) Cancer Res. 37, 4112-4119.
21. Thomas, L. (1959) in Cellular and Humoral Aspects of the Hypersensitive States, ed. Lawrence, H. S. (Hoeber-Harper, New York), p. 529.
22. Burnet, F. (1970) Immunological Surveillance (Pergamon, Oxford).
23. Conforti, A., Ollila, D., Kelley, M., Gammon, G. & Morton, D. (1997) J. Surg. Oncol. 66, 55-64.
24. Wallack, M., Sivanandham, M., Ditaranto, K., Shaw, P., Balch, C., Urist, M., Bland, K., Murray, D., Robinson, W., Flaherty, L., et al. (1997) Ann. Surg. 226, 198-206.
25. Stutman, O. (1969) Science 166, 620-621.
26. Engel, A., Svane, I., Rygaard, J. & Werdelin, O. (1997) Scand. J. Immunol. 45, 463-470.
27. Svane, I., Engel, A., Nielsen, M., Ljunggren, H., Rygaard, J. & Werdelin, O. (1996) Eur. J. Immunol. 26, 1844-1850.
28. Noguchi, Y., Jungbluth, A., Richards, E. & Old, L. (1996) Proc. Natl. Acad. Sci. USA 93, 11798-11801.
29. Olerup, O. & Emtestam, L. (1988) Immunogenetics 28, 310-313.
30. Hirvonen, A., Hersgafvel-Pursiainen, K., Antilla, S., Karjalainen, A. & Vainio, H. (1993) Environ. Health Perspect. 101, 109-112.